Results 141 to 150 of about 418,673 (161)

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Diabetes Care, 2015
Philip D Home, Richard M Bergenstal, Matthew C Riddle   +2 more
exaly  

Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus

Drugs, 2016
Hannah A Blair, Gillian M Keating
exaly  

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

Diabetes, Obesity and Metabolism, 2015
Ronan Roussel
exaly  

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Diabetes Care, 2012
Bernard Zinman, Bertrand Cariou, Athena Philis-Tsimikas   +2 more
exaly  

New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1

Diabetes Care, 2015
Reinhard H A Becker, Tim Heise
exaly  

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes

Diabetes Care, 2012
Reinhard H A Becker, Tim Heise, Geremia B Bolli   +2 more
exaly  

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Diabetes, Obesity and Metabolism, 2016
M J Prince, L L Ilag, S V Edelman
exaly  

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy

Diabetic Medicine, 2007
Thomas Pieber
exaly  

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

Diabetologia, 2009
Rickard Ljung, Gunnar Steineck, Junmei Miao Jonasson   +2 more
exaly